About Oncoradiomics
Oncoradiomics is a public limited company (NV/SA) based in Liège, founded in 2016. Its main activity is classified as "Speur- en ontwikkelingswerk op biotechnologisch gebied". For the 2025 financial year, Oncoradiomics reported a profit of €284,677. A year earlier, in 2024, it still made a loss of €1.2 million. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €2.4 million, up 88% on 2024. It employed an average of 12.8 full-time equivalents. Equity is negative (-€3,807): liabilities exceed assets. In 2017 it was -€283,123. 9 annual accounts are available, covering 2017 to 2025.
- Signals
-
Negative equityNegative equity € -4K
Equity is negative: debts exceed assets (technically insolvent).
Poor liquidityPoor liquidity 0.34The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 285KThe company reported a positive net result in the latest financial year.
Positive cashflowPositive cashflow € 732KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 858KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 8.5%Social debts stay manageable relative to personnel costs.
- Directors
- Dxorange B.v. Bo, Noshaq Partners Scrl, Bernard Surlemont, +1 more
- Shareholders
- Benelux Health Ventures, Hi-Tech Invest 49,58%, Noshaq 5,33%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
2.37M
|
€
1.26M
|
€
877K
|
€
311K
|
|
|
€
858K
|
€
-302K
|
€
-920K
|
€
-1.41M
|
|
|
€
285K
|
€
-1.15M
|
€
-1.90M
|
€
-2.37M
|
|
|
€
-4K
|
€
-1.02M
|
€
-3.61M
|
€
-1.76M
|
|
|
-0.09%
|
-26.9%
|
-119.65%
|
-47.95%
|
|
|
€
4.31M
|
€
4.82M
|
€
6.64M
|
€
5.42M
|
|
|
€
9K
|
€
1.00M
|
€
1.20M
|
€
2.20M
|
|
|
12.80
|
23.70
|
23.60
|
30.10
|
Publications 11
All publicationsFrequently asked questions
Answers to the most common questions about Oncoradiomics, based on official government data and the filed annual accounts.
What is the VAT number of Oncoradiomics?
The VAT number of Oncoradiomics is BE0662.719.440.
How many employees work at Oncoradiomics?
In 2025, Oncoradiomics employed 12.80 full-time equivalents (FTE).
When was Oncoradiomics established?
Oncoradiomics was founded in 19-09-2016.
What is the official address of Oncoradiomics?
The official address of Oncoradiomics is Boulevard De Patience Et Beaujonc 3 Liège 4000.
What is the legal form of Oncoradiomics?
The juridical form of Oncoradiomics is Public limited company (NV/SA).
What is the annual revenue of Oncoradiomics?
The 2025 accounts of Oncoradiomics do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Oncoradiomics a reliable company?
Oncoradiomics is a registered Rechtspersoon with company number 0662.719.440 and can be verified through the official CBE database.
What is the credit limit of Oncoradiomics?
The estimated credit limit of Oncoradiomics is €604,691.
Is Oncoradiomics still active?
Oncoradiomics currently has the status "Normal situation" and is active.